Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I stand corrected, thank you very much for that.
I couldn't help but notice that when you max out the stock charts for BMSN at one point it was valued above $1. It has since then lost 99% of it's value to this point.
Does anyone know the appologetics for this or what happened?
Bear raid to trigger people's automatic stop losses.
You can see obviously that the artificially low price was rejected.
On October 24,2011 a Complaint (“Complaint”) was filed in the Superior Court of the State of California, County of San Diego Central Division against the Company, the Company’s Chairman, and American Stock Transfer and Trust Company LLC by Rick Plote. The Complaint seeks damages from the defendants jointly and severally of no less than $615, 000 and alleges breach of written agreement, breach of written guarantee and fraud in connection with the defendant’s failure to transfer 4,000,000 common shares of the Company beneficially owned by the company’s Chairman and CEO and pledged by the Company’s Chairman to secure payment of a promissory note issued by an unaffiliated third party.
Sounds more like a tiff around transferring stock than the actual efficacy of the company. BTW these charges remain alleged.
By the way for those who haven't seen it. This is the 10k form for the SEC. It's an interesting must-read.
http://www.sec.gov/Archives/edgar/data/1079282/000155479513000119/bmsn03062013form10k.htm
The 10k shouldn't raise any more fears than those that already existed. People here should recognize that BMSN is of course speculative. I think having all the potential pitfalls shoved in their face from the 10k is turning people scared.
In 10k forms they HAVE to say every possibly way the company could spontaneously combust. If they don't and something happens they're held liable. Worry not, reread the DD on this board and chipper on. BMSN remains excellent and the IND approval is going to improve the pps regardless of long term worries.
Yeah that's what I meant, no rush people. No need to jump in just yet if you can't.
Technically there's next week as well. I wouldn't say this is the LAST day.
That is unlikely seeing as they really have nothing to report at this time, other than affirming 'hey guys we're still around and our hearts are beating. Chipper on'
He likes to type stream of conscious, though he did get lucky with a few price projections.
http://www.fda.gov/drugs/resourcesforyou/consumers/ucm143534.htm
Where along in this process if CTIX currently?
Uh, I just went back through the pages and read his posts. It's not that hard. I wanted to see what people were saying he seemed like the most articulate critic.
Alright, I'm not 100% convinced. But it does appear I was mistaken. It does seem though that it is a mandated regulation that ALL submitted IND's must have a "response" given to them with in a 30day time period.
Spare the ad homs. Find me where it says anything about the application being automatically approved.
Nothing about trials, the application is what I'm talking about.
There's still nothing about the approval of the application. Can someone find a page anywhere on FDA policy that mentions a 30 day rule? You'd think somewhere it would be stated explicitly.
Where does it say "30 days after IND Application, unless the FDA points out contrary to the application,
it shall be automatically accepted (30 day rule)." on there?
The quote about 30 days only refers to the companies trials, nothing about automatic approval of an IND application.
Source?
I'm not saying the drug itself is being approved either, but there is no automatic 30 day approval for the application it's just a waiting period for the company of it's own volition to start trials. Nothing to do with the FDA.
I've been reading people claim that there's an automatic 30 day threshold for an FDA go ahead for trials. This is clearly not the case.
The page everyone cites is either the old one from the 1990's or only refers to a waiting period for the company to START trials, nothing on FDA approval for the trial itself.
Since when was skepticism 'negative posts'? Everyone has to start some time.
The link you provided just says " Once the IND is submitted, the sponsor must wait 30 calendar days before initiating any clinical trials."
That's just for the company to start the trials, its says nothing on FDA approval itself.
I have, those are my remaining questions. No one has provided any proof, as InvestorStemCell pointed out, the 30 day rule is bogus.
I'm always suspicious when most of the people who are spouting hype on one of these hubs appear to have double digit IQ's.
Where's everyone evidence that first the share price will be ~$0.10
That seems like pure speculation.
Also, evidence for the 30 day IND rule?
This looks like a massive hype train.
I've looked back and nobody could ever address InvestorStemCell's points.
$0.10
Then what?
Just found this board. Can someone get me up to speed quickly? What are we looking at?
To those who created this board. how did you find CTIX in the first place? I can appreciate excellent DD when I see it but how did you first come acquainted? Where did you look?
Also, I'd like to apologize for my earlier posts. I wasn't aware of the information the patient ones here provided for me.
I was about 80% ready to fall in behind this stock but those questions remained. So, thanks to all for the clarifications. I am not risk adverse, but that doesn't mean I like to charge in blindly.
$4-$5?
I've seen everything now...
I've seen $5 predictions, I've seen $50 predictions, I've seen $150 dollar predictions.
Can anyone show some math on the matter? How much would the market for a cancer treating drug like Kevetrin amass?
"If you question the data surrounding K, ask DF, BIMC, U of Bologna, MD Anderson, etc. They all seem to have found it extremely interesting and worthwhile to pursue."
> Appeal to authority. Citations?
I mean these are likely relying on CTIX's own preclinical data for introduction into trials at the institutions. The CTIX preclinicals I call into question, seeing as the Menon-owned KARD presents a conflict of interest.
The only things I've found on Menon are CTIX declarations which as part of my DD process I have to disregard in preservation of skepticism, seeking alpha articles that can be written by anyone, and stray webpages that aren't linked to any institution of public trust. Has anyone actually read the patents? If so what are your findings? I'm in process of grabbing a Uni professor to look them over.
I'd like to ask also for people not to fixate on me personally and simply stick to the facts and reason. I wholly admit I could be wrong, that's why I came here, if I am right I'd like to prevent people from losing their money as well.
Link to the Beth Israel declaration?
I had posted about this earlier but didn't get any concrete replies on the matter.
Can we got concrete non-CTIX sources for Menon's background? I've seen conflicting reports about whether he went to Harvard or not, as well as his papers or alleged lack thereof in journal publications.
Not to mention, can we find ANY non-CTIX source that Kevetrin actually works? I remain skeptical since many of the early trials were done at KARD (owned by Menon.)
And finally in the vivo tumor update a bit back, what does "tumor shrinkage" mean. Did it shrink 1%? Did it shrink enough to realistically combat cancer?
These are questions that should be asked instead of fantasizing about the payoff. I'm not bashing, alright I know it's easy to just dismiss or get emotional when someone comes questioning the dream, but these questions need to be asked.
I'm trying to vette the stock before I throw more money into it without using CTIX sources. I remain very skeptical of because honestly they post a PR for very bizarre things. Can you find non-CTIX sources to confirm any of their claims ever?
Also as for the insider's owning bit they could just be pumping to a certain level to throw off their own shares. Now I'm not saying this IS the case, but it is certainly possible. Not to mention, has anyone considered the possibility of dilution?
I get that the study is done at Beth Israel and that's certainly a prestigious institution but we must not conflate prestige with merit here. I mean can't anyone with the right amount of money put up trials there? I don't think the institution itself should be indicator of the outcome for Kevetrin.
And I mean, what does "tumor shrinkage" mean. Did it shrink 1%? Did it shrink to a point where this could realistically combat cancer? I'm looking for indications, even in a preclinical sense, that this actually works.
This is my last post for the day so I'd like to ask: What are everyone's high point share projections if this does end up working?
Everybody has to start at sometime, I've been ghosting for a while and these are my concerns.
Can you address them? I think it's in everybody's best interest if they don't just get a continuous round of hype. A healthy dose of skepticism is always no harm.